The WADA Prohibited List: How It Is Compiled

Every year on 1 January a new version of the WADA Prohibited List comes into force, and every athlete under the anti-doping system is bound by it. Few know how substances get on, or off, that list. The process is more structured than many assume, with clear criteria, scientific committees and an annual consultation cycle.
What the Prohibited List is
The Prohibited List is one of the International Standards that sit beneath the World Anti-Doping Code. It defines which substances and methods are banned, and whether they are prohibited at all times or only in competition.
The list is mandatory for all signatories of the Code, which include the International Olympic Committee, international federations and national anti-doping organisations such as UK Anti-Doping (UKAD).
In the UK, UKAD implements the Code through the UK National Anti-Doping Policy. Athletes in sports whose governing bodies have adopted the policy are subject to testing and sanctions according to the current list.
The list is published at least three months before it takes effect, normally by 1 October, to give athletes, doctors and support staff time to adapt.
The three criteria for inclusion
Article 4.3 of the Code sets out the criteria. A substance or method may be added if it meets any two of the following three:
- It has the potential to enhance, or enhances, sport performance.
- It represents an actual or potential health risk to the athlete.
- Its use violates the spirit of sport, as described in the Code.
Substances that can mask the use of other prohibited substances may be included on that basis alone. Diuretics and plasma expanders are the classic examples.
WADA's decision to include a substance is final and cannot be challenged by an athlete on the grounds that it does not truly enhance performance. This was a deliberate design choice to prevent endless litigation.
Critics argue that the "spirit of sport" criterion is vague. A review by Heuberger and Cohen concluded that, for many listed substances, published evidence of performance enhancement is limited, which fuels ongoing debate about the criteria.

Who decides and how
The list is prepared by WADA's Prohibited List Expert Advisory Group, made up of scientists and clinicians with expertise in pharmacology, endocrinology, analytical chemistry and sports medicine.
The group reviews new scientific literature, intelligence from laboratories and investigations, data from the Monitoring Program and requests from stakeholders. Emerging substances, for example new SARMs or peptide analogues, are often identified through seizures and laboratory findings.
A draft is circulated to stakeholders for consultation, usually around mid-year. Governments, federations, athletes' committees and national agencies can submit comments, which the expert group considers.
The Health, Medical and Research Committee then makes a recommendation, and WADA's Executive Committee approves the final list, typically in September.
Structure of the list
The list is organised into categories. Some are prohibited at all times, while others apply only in competition or only in particular sports.
| Category | Examples of class | When prohibited |
|---|---|---|
| S0 Non-approved substances | Drugs without human therapeutic approval | At all times |
| S1 Anabolic agents | Anabolic steroids, SARMs | At all times |
| S2 Peptide hormones and growth factors | EPO, growth hormone | At all times |
| S3–S5 | Beta-2 agonists, hormone and metabolic modulators, diuretics | At all times |
| M1–M3 Methods | Blood manipulation, tampering, gene doping | At all times |
| S6–S9 | Stimulants, narcotics, cannabinoids, glucocorticoids | In competition |
| P1 Beta-blockers | Propranolol and others | In particular sports |
Many categories end with a clause covering "other substances with a similar chemical structure or similar biological effect(s)". This prevents designer analogues from escaping the rules simply because they are not named.
Since 2021 the Code has also identified "Substances of Abuse", such as cocaine and cannabis, which can attract reduced sanctions when use occurs out of competition and is unrelated to sport performance.
Monitoring, exemptions and practical use
WADA runs a Monitoring Program for substances that are not prohibited but whose patterns of use are tracked. Caffeine, for instance, was removed from the list in 2004 and has since been monitored. Data from the programme can lead to future inclusion.
Athletes with genuine medical needs can apply for a Therapeutic Use Exemption (TUE). In the UK, this is handled by UKAD or by the relevant international federation, depending on the athlete's level.
For day-to-day checks, Global DRO allows athletes in the UK to look up the status of specific medicines bought in the UK. It is updated to reflect each new list.
Supplements are not covered by Global DRO, because their contents are not guaranteed. Athletes are advised to use batch-tested products and to keep records of what they take.
Conclusions of the editorial team
The WADA Prohibited List is built on explicit criteria: any two of performance enhancement, health risk and violation of the spirit of sport, plus a separate rule for masking agents.
An expert group drafts the list each year, stakeholders comment, and the Executive Committee approves it for publication by October and entry into force on 1 January.
Athletes should check medicines through official tools, apply for TUEs where needed and treat supplements with caution.
Related topics: supplements and the risk of inadvertent doping, how Therapeutic Use Exemptions work, and what happens after an adverse analytical finding.
References
- World Anti-Doping Agency. World Anti-Doping Code 2021. Montreal: WADA; 2021.
- World Anti-Doping Agency. International Standard: Prohibited List. Montreal: WADA; published annually.
- Heuberger JAAC, Cohen AF. Review of WADA prohibited substances: limited evidence for performance-enhancing effects. Sports Med. 2019;49(4):525–539.
- Kayser B, Mauron A, Miah A. Current anti-doping policy: a critical appraisal. BMC Med Ethics. 2007;8:2.
- UK Anti-Doping. UK National Anti-Doping Policy. London: UKAD; 2021.


